Coreia do Sul has become a significant force in hyaluronic acid dermal filler innovation, producing CE-marked products that compete directly with established Western brands in European aesthetic markets. Korean HA filler manufacturers have invested in advanced cross-linking technologies, producing products with well-characterised rheological profiles and strong clinical track records.
Korean Filler de AH Technology
The key determinant of HA filler performance is cross-linking — the process that creates a durable gel matrix from linear HA chains. Korean manufacturers have developed their own proprietary cross-linking approaches:
Revolax (Across Corp.) uses BDDE cross-linking at 24mg/ml to create a high-viscosity monophasic gel with strong lifting capacity.
Neuramis (Medytox) uses the SHAPE (Smooth Ácido Hialurónico Particle Engineering) technology to produce a uniquely homogeneous, smooth-flowing gel.
CE Marking
Both Revolax Deep and Neuramis Deep carry CE marking, confirming conformity with EU medical device regulations. CE-marked HA fillers must meet biocompatibility, sterility, and labelling requirements.
Clinical Applications
Korean deep HA fillers are suitable for: nasolabial fold correction, marionette lines, chin projection, cheek augmentation, jawline definition, and lip border enhancement. Duração typically 12–18 months.